Shen CY - Search Results

1

The role of BRCA1 in non-homologous end-joining.

Bau DT, Mau YC, Shen CY. Bau DT, et al. Among authors: shen cy. Cancer Lett. 2006 Aug 18;240(1):1-8. doi: 10.1016/j.canlet.2005.08.003. Epub 2005 Sep 19. Cancer Lett. 2006. PMID: 16171943 Review.

2

Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.

Tseng SL, Yu IC, Yue CT, Chang SF, Chang TM, Wu CW, Shen CY. Tseng SL, et al. Among authors: shen cy. Genes Chromosomes Cancer. 1997 Dec;20(4):377-82. Genes Chromosomes Cancer. 1997. PMID: 9408754

3

Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).

Lo YL, Yu JC, Huang CS, Tseng SL, Chang TM, Chang KJ, Wu CW, Shen CY. Lo YL, et al. Among authors: shen cy. Int J Cancer. 1998 Dec 18;79(6):580-7. doi: 10.1002/(sici)1097-0215(19981218)79:6<580::aid-ijc5>3.0.co;2-m. Int J Cancer. 1998. PMID: 9842965 Free article.

4

Screen for MAOA mutations in target human groups.

Schuback DE, Mulligan EL, Sims KB, Tivol EA, Greenberg BD, Chang SF, Yang SL, Mau YC, Shen CY, Ho MS, Yang NH, Butler MG, Fink S, Schwartz CE, Berlin F, Breakefield XO, Murphy DL, Hsu YP. Schuback DE, et al. Among authors: shen cy. Am J Med Genet. 1999 Feb 5;88(1):25-8. Am J Med Genet. 1999. PMID: 10050962 Free PMC article.

5

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Huang CS, et al. Among authors: shen cy. Cancer Res. 1999 Oct 1;59(19):4870-5. Cancer Res. 1999. PMID: 10519398

6

Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.

Shen CY, Yu JC, Lo YL, Kuo CH, Yue CT, Jou YS, Huang CS, Lung JC, Wu CW. Shen CY, et al. Cancer Res. 2000 Jul 15;60(14):3884-92. Cancer Res. 2000. PMID: 10919664

7

Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.

Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE, Shen CY. Fu YP, et al. Among authors: shen cy. Cancer Res. 2003 May 15;63(10):2440-6. Cancer Res. 2003. PMID: 12750264

8

Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade.

Ding SL, Sheu LF, Yu JC, Yang TL, Chen BF, Leu FJ, Shen CY. Ding SL, et al. Among authors: shen cy. Br J Cancer. 2004 May 17;90(10):1995-2001. doi: 10.1038/sj.bjc.6601804. Br J Cancer. 2004. PMID: 15138484 Free PMC article.

9

Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.

Bau DT, Fu YP, Chen ST, Cheng TC, Yu JC, Wu PE, Shen CY. Bau DT, et al. Among authors: shen cy. Cancer Res. 2004 Jul 15;64(14):5013-9. doi: 10.1158/0008-5472.CAN-04-0403. Cancer Res. 2004. PMID: 15256476

10

Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.

Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY. Cheng TC, et al. Among authors: shen cy. Int J Cancer. 2005 Jan 20;113(3):345-53. doi: 10.1002/ijc.20630. Int J Cancer. 2005. PMID: 15455371 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

632 results

Search Page